20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans

Diabetes Research and Clinical Practice

Volumn 74, Issue 2, 2006, Pages 197-200

  Ward, Natalie C ^a   Hodgson, Jonathan M ^a   Puddey, Ian B ^a   Beilin, Lawrence J ^a   Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

20 HETE; Blood pressure; BMI; Hypertension; Insulin resistance

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CIRCULATION; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; URINARY EXCRETION;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INSULIN; MALE; MIDDLE AGED; OVERWEIGHT; REFERENCE VALUES; THINNESS;

EID: 33751101400     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.04.001     Document Type: Article

References (13)

1. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J. Clin. Endocrinol. Metab. 88 (2003) 2399-2403
2. Bloomgarden Z.T. Obesity, hypertension, and insulin resistance. Diabetes Care 25 (2002) 2088-2097
3. Imazu M. Hypertension and insulin disorders. Curr. Hypertens. Rep. 4 (2002) 477-482
4. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
5. Ward N.C., Rivera J., Hodgson J., et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110 (2004) 438-443
6. Hong C.C., Tang B.K., Hammond G.L., et al. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res. 6 (2004) R352-R365
7. Bergman R.N., and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11 (2000) 351-356
8. Akiba S., and Sato T. Cellular function of calcium-independent phospholipase A2. Biol. Pharm. Bull. 27 (2004) 1174-1178
9. Laffer C.L., Laniado-Schwartzman M., Nasjletti A., and Elijovich F. 20-HETE and circulating insulin in essential hypertension with obesity. Hypertension 43 (2004) 388-392
10. Laffer C.L., Laniado-Schwartzman M., Wang M., Nasjletti A., and Elijovich F. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation 107 (2003) 574-578
11. Rivera J., Ward N., Hodgson J., Puddey I.B., Falck J.R., and Croft K.D. Measurement of 20-hydroxyeicosatetraenoic acid in human urine by gas chromatography-mass spectrometry. Clin. Chem. 50 (2004) 224-226
12. Becker W., Kluge R., Kantner T., et al. Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycemia: evidence for a combined transcriptional dysregulation of gluconeogenesis and fatty acid synthesis. J. Mol. Endocrinol. 32 (2004) 195-208
13. Shimojo N., Ishizaki T., Imaoka S., Funae Y., Fujii S., and Okuda K. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol. 46 (1993) 621-627